Problems of vascular pathology of the brain in the concept of cerebrometabolic health
- 00:03:47
Metabolic syndrome increases risk of stroke by more than 2 times
- 00:07:12
'Obesity Paradox' Disappears When Waist Circumference Is Measured
- 00:09:42
Brain insulin resistance is a key mechanism of damage
- 00:19:24
Hyperglycemia in stroke: control does not improve outcome
- 00:23:23
EPICA Study: Mexidol Improves Stroke Outcomes
Ksenia Valentinovna Antonova , MD, PhD, endocrinologist, leading researcher at the Russian Center for Neurology and Neurosciences
Announcement:
, an endocrinologist and leading researcher at the Russian Center for Neurology and Neurosciences, Ksenia Valentinovna Antonova will discuss:
- Why the 'obesity paradox' disappears when assessing visceral fat;
- How Metabolic Syndrome More Than Doubles Stroke Risk;
- Why Glycemic Control Doesn't Work in Acute Stroke;
- How does the drug Mexidol affect insulin resistance, oxidative stress and microcirculation?
According to the results of the EPICA study, significant improvement in the NIHSS and mRS scales was observed in patients with stroke and type 2 diabetes while taking Mexidol.
This video lecture is a must-see for neurologists, cardiologists, endocrinologists and therapists!
- 00:03:47
Metabolic syndrome increases risk of stroke by more than 2 times
- 00:07:12
'Obesity Paradox' Disappears When Waist Circumference Is Measured
- 00:09:42
Brain insulin resistance is a key mechanism of damage
- 00:19:24
Hyperglycemia in stroke: control does not improve outcome
- 00:23:23
EPICA Study: Mexidol Improves Stroke Outcomes